Citadel Advisors
EVOJW

Citadel Advisors’s Evo Acquisition Corp. Warrant EVOJW Stock Holding History

Citadel Advisors’s Portfolio EVOJW Stock Details EVOJW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-22,291
Closed -$12K – 15164
2021
Q3 		$12K Buy
+22,291
New +$14.4K ﹤0.01% 13678

Other funds holding EVOJW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
MCP
Maso Capital Partners Hong Kong $60.9M AUM 0.32% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
HCM
Hawkeye Capital Management Miami Beach, Florida $40.6M AUM 11.3% 1-Year Est. Return

Citadel Advisors's EVOJW Position: Q4 2021 in Review

Citadel Advisors sold out of Evo Acquisition Corp. Warrant (EVOJW) in Q4 2021, closing a stake of 22,291 shares — an estimated $12K sold.

Citadel Advisors first reported a position in EVOJW in Q3 2021 and held it in 1 quarter. The position peaked at $12K in Q3 2021. 40 funds tracked by Wall St. Rank hold EVOJW as of Q4 2021.

  • Citadel Advisors reported no remaining Evo Acquisition Corp. Warrant position as of Q4 2021 after selling out during the quarter.
  • Citadel Advisors sold 22,291 Evo Acquisition Corp. Warrant shares in Q4 2021, an estimated $12K.
  • Citadel Advisors first reported a position in Evo Acquisition Corp. Warrant in Q3 2021 and held it in 1 quarter.
  • Citadel Advisors's Evo Acquisition Corp. Warrant position peaked at $12K in Q3 2021.
  • 40 funds tracked by Wall St. Rank held Evo Acquisition Corp. Warrant as of Q4 2021.

Based on Citadel Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.